News | May 15, 2012

Cancer Experts Detail Using TrueBeam to Reduce Treatments, Better Account of Motion

More than 500 oncology professionals at European Society for Radiotherapy and Oncology congress hear of breakthrough treatments using high dose rate capability of Varian's advanced TrueBeam™ system with RapidArc Radiosurgery

May 15, 2012 -- European cancer experts have reported their progress with promising new radiosurgical techniques for treating cancer and other conditions using new linear accelerator technology from Varian Medical Systems. Speakers at Varian's Emerging Technologies Symposium at the annual ESTRO conference detailed their experiences with fast hypo-fractionated treatments for prostate patients and RapidArc Radiosurgery for intracranial and central nervous system indications.

Dr. Filippo Alongi, radiation oncologist at Humanitas Cancer Center in Rozzano-Milan, reported that he has used hypo-fractionation to reduce the number of treatment sessions for prostate cancer from 30 to as few as five. The center is equipped with Varian's versatile TrueBeam system for radiotherapy and radiosurgery. 

"Our work at Humanitas is demonstrating that hypo-fractionation with TrueBeam is a precise and fast option for prostate cancer patients," said Dr. Alongi. "Each treatment is delivered in under five minutes and this compares very favorably against dedicated radiosurgical tools which can take 45 minutes per treatment session. We are giving the same dose with the same quality in a fraction of that time, and enabling patients to spend much less time on the treatment table."

Dr. Ufuk Abacioglu of Neolife Medical Center in Istanbul presented on the use of frameless, singe-fraction RapidArc® Radiosurgery for intracranial and central nervous system treatments, including malignant and benign tumors, vascular abnormalities and functional disorders. 

"Frameless, non-invasive localization of the target with image-guidance has made it possible for us to treat larger disease sites in fewer sessions while avoiding the invasive procedure of attaching a frame to the patient's skull," said Dr. Abacioglu. "Using TrueBeam's ultra-fast high-intensity mode, image-guided radiosurgery can be completed in a standard 15-minute treatment slot rather than in conventional radiosurgery sessions that are typically two to five times longer. We are pleased with the clinical experience and patient response."

Prof. Carlo Greco from the University of Pisa in Italy described his clinic's experience with real-time tracking of prostate cancer using the Varian Calypso® system, which involves the use of implantable beacons to monitor motion by tracking movement in real time with sub-millimeter precision.

"Calypso enabled us to detect and measure motion during treatments so that we could plan to deliver doses within tighter margins around the disease site in order to reduce toxicity and complications in surrounding healthy tissue," said Prof. Greco. "Prostate motion occurs even during very short RapidArc treatments and detecting and correcting for this is of paramount importance when adopting hypo-fractionated schedules that involve delivering higher doses within each treatment session."

The Varian's Emerging Technologies Symposium was chaired and moderated by Professor Ben Slotman, head of radiation oncology at VU Medical Center in Amsterdam, The Netherlands.

Also at ESTRO 2012, Varian hosted a lunch symposium assessing different ways of delivering post-lumpectomy partial breast irradiation, with the relative benefits of external beam radiotherapy, intra-operative irradiation and brachytherapy examined. This session was moderated by Prof. Dr. Peter Niehoffof Koln Merheim Hospital in Germany and the debaters were Douglas Arthur, M.D. of Virginia Commonwealth University School of Medicine in the USA and Frank Sullivan, M.D. of Galway University Hospital in Ireland.  

For more information: www.varian.com

Related Content

New Prostate Cancer Radiotherapy Technique Aims to Preserve Sexual Function
News | Radiation Therapy | June 18, 2018
A multicenter clinical trial being led by UT Southwestern physicians is testing a technique for sparing nerve bundles...
Elekta Unity High-Field MR-Linac Receives CE Mark
News | Image Guided Radiation Therapy (IGRT) | June 18, 2018
Elekta announced that its Elekta Unity magnetic resonance radiation therapy (MR/RT) system has received CE mark,...
Washington University in St. Louis Begins Clinical Treatments With ViewRay MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | June 14, 2018
June 14, 2018 — The Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in S
Accuray TomoTherapy System Beneficial in Two Total Body Irradiation Studies
News | Radiation Therapy | June 13, 2018
Recently published data from two new studies demonstrate the benefits of Accuray’s TomoTherapy System in the delivery...
IsoRay Funding Brain Cancer Treatment Research With Ochsner Clinic Foundation
News | Brachytherapy Systems | June 12, 2018
IsoRay Inc. announced the initiation of research funding for brain cancer treatment to Ochsner Clinic Foundation, a not...
News | Brachytherapy Systems | June 07, 2018
IsoRay Inc. announced the upcoming release of its Build-Blu delivery system for real-time prostate brachytherapy.
Raysearch RayStation
Feature | Radiation Therapy | June 05, 2018 | By Melinda Taschetta-Millane
Treatment planning systems are at the heart of r...
Beaumont Researchers Invent New Mode of Proton Treatment for Lung Cancer
News | Proton Therapy | May 31, 2018
Members of Beaumont Health’s proton therapy team presented research on a new treatment for patients with lung cancer at...
More Than 60 Percent of Patients Seeking Proton Therapy Initially Denied Coverage
News | Proton Therapy | May 25, 2018
The Alliance for Proton Therapy Access has released a national report revealing the heavy emotional and financial...
News | Treatment Planning | May 24, 2018
Daniela Schmitt, Ph.D., took top honors in the overall category of the 2018 TROG Plan Study: Stereotactic Radiosurgery...
Overlay Init